Abstract In 1996 and 2011, the American Society of Hematology (ASH) supported efforts to
create guidelines for the diagnosis and management of patients with immune …

Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the
American Society of Hematology published a landmark guidance paper designed to assist …

Background: Despite an increase in the number of therapies available to treat patients with
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …

Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

Very few data exist on the management of adult patients diagnosed with primary immune
thrombocytopenia (ITP). The objectives of this study were to describe the diagnostic and …

New insights into the pathophysiology and the natural history of immune thrombocytopenia
(ITP) and new therapeutical approaches have emerged in the last 10 years that have made …

Previously published guidelines for the diagnosis and management of primary immune
thrombocytopenia (ITP) require updating largely due to the introduction of new classes of …

Immune thrombocytopenia (ITP) is an autoimmune-mediated condition that results from
antibody-mediated destruction of platelets and impaired megakaryocyte platelet production …

Despite the availability of therapies to treat patients with immune thrombocytopenia (ITP),
there is currently little data from randomized trials to assist clinicians in managing patients …

Immune thrombocytopenic purpura (ITP) is an autoimmune condition that affects nearly 1:
10,000 people in the world. It is traditionally defined by a platelet count of less than 100 x 10 …